πŸ‡ΊπŸ‡Έ FDA
Patent

US 8501926

Malaria vaccine

granted A61KA61K2039/505A61K2039/55505

Quick answer

US patent 8501926 (Malaria vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K2039/55505, A61K2039/55566, A61K39/015